W. Casan Scott

Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent.

A comparative understanding of effluent quality of decentralized on-site wastewater treatment systems, particularly for contaminants of emerging concern (CECs), remains less understood than effluent quality from centralized municipal wastewater treatment plants. Using a novel experimental facility with common influent wastewater, effluent water quality from a decentralized advanced aerobic treatment system (ATS) and a typical septic treatment system (STS) coupled to a subsurface flow constructed wetland (WET) were compared to effluent from a centralized municipal treatment plant (MTP). The STS did not include soil treatment, which may represent a system not functioning properly. Occurrence and discharge of a range of CECs were examined using isotope dilution liquid chromatography-tandem mass spectrometry during fall and winter seasons. Conventional parameters, including total suspended solids, carbonaceous biochemical oxygen demand and nutrients were also evaluated from each treatment system. Water quality of these effluents was further examined using a therapeutic hazard modeling approach. Of 19 CECs targeted for study, the benzodiazepine pharmaceutical diazepam was the only CEC not detected in all wastewater influent and effluent samples over two sampling seasons. Diphenhydramine, codeine, diltiazem, atenolol, and diclofenac exhibited significant (p<0.05) seasonal differences in wastewater influent concentrations. Removal of CECs by these wastewater treatment systems was generally not influenced by season. However, significant differences (p<0.05) for a range of water quality indicators were observed among the various treatment technologies. For example, removal of most CECs by ATS was generally comparable to MTP. Lowest removal of most CECs was observed for STS; however, removal was improved when coupling the STS to a WET. Across the treatment systems examined, the majority of pharmaceuticals observed in on-site and municipal effluent discharges were predicted to potentially present therapeutic hazards to fish.

Pharmaceutical bioaccumulation by periphyton and snails in an effluent-dependent stream during an extreme drought

Increasing evidence indicates that pharmaceutical bioaccumulate in fish collected downstream from municipal wastewater effluent discharges. However, studies of pharmaceutical bioaccumulation by other aquatic organisms, including primary producers (e.g., periphyton) and grazers (e.g., snails), are lacking in wadeable streams. Here, we examined environmental occurrence and bioaccumulation of a range of pharmaceuticals and other contaminants of emerging concern in surface water, a common snail (Planorbid sp.) and periphyton from an effluent-dependent stream in central Texas, USA, during a historic drought, because such limited dilution and instream flows may represent worst-case exposure scenarios for aquatic life to pharmaceuticals. Water and tissue samples were liquid-liquid extracted and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) with electrospray ionization. Target analytes included 21 pharmaceuticals across multiple drug classes and 2 pharmacologically active metabolites. Several pharmaceuticals were detected at up to 4.7 μg kg(-1) in periphyton and up to 42 μg kg(-1) in Planorbid sp. We then identified limitations of several bioconcentration factor and bioaccumulation factor models, developed for other invertebrates, to assist interpretation of such field results. Observations from the present study suggest that waterborne exposure to pharmaceuticals may be more important than dietary exposure for snails.

Bioaccumulation of human pharmaceuticals in fish across habitats of a tidally influenced urban bayou

Though pharmaceuticals and other contaminants of emerging concern are increasingly observed in inland water bodies, the occurrence and bioaccumulation of pharmaceuticals in estuaries and coastal ecosystems are poorly understood. In the present study, bioaccumulation of select pharmaceuticals and other contaminants of emerging concern was examined in fish from Buffalo Bayou, a tidally influenced urban ecosystem that receives effluent from a major (∼200 million gallons per day) municipal wastewater treatment plant in Houston, Texas, USA. Using isotope dilution liquid chromatography-tandem mass spectrometry, various target analytes were observed in effluent, surface water, and multiple fish species. The trophic position of each species was determined using stable isotope analysis. Fish tissue levels of diphenhydramine, which represented the only pharmaceutical detected in all fish species, did not significantly differ between freshwater and marine fish predominantly inhabiting benthic habitats; however, saltwater fish with pelagic habitat preferences significantly accumulated diphenhydramine to the highest levels observed in the present study. Consistent with previous observations from an effluent-dependent freshwater river, diphenhydramine did not display trophic magnification, which suggests site-specific, pH-influenced inhalational uptake to a greater extent than dietary exposure in this tidally influenced urban ecosystem. The findings highlight the importance of understanding differential bioaccumulation and risks of ionizable contaminants of emerging concern in habitats of urbanizing coastal systems.

Predicted and observed therapeutic dose exceedances of ionizable pharmaceuticals in fish plasma from urban coastal systems.

Instream flows of the rapidly urbanizing watersheds and estuaries of the Gulf of Mexico in Texas (USA) are increasingly dominated by reclaimed waters. Though ionizable pharmaceuticals have received increasing attention in freshwaters, many research questions remain unanswered, particularly in tidally influenced urban coastal systems, which experience significant spatiotemporal variability in pH that influences bioavailability and bioaccumulation. The authors coupled fish plasma modeling of therapeutic hazard values with field monitoring of water chemistry variability and pharmaceutical occurrence to examine whether therapeutic hazards to fish existed within these urban coastal ecosystems and whether therapeutic hazards differed within and among coastal locations and seasons. Spatial and temporal fluctuations in pH within study sites altered the probability of encountering pharmaceutical hazards to fish. Significant water quality differences were consistently observed among traditional parameters and pharmaceuticals collected from surface and bottom waters, which are rarely sampled during routine surface water quality assessments. The authors then compared modeling predictions of fish plasma concentrations of pharmaceuticals to measured plasma levels from various field-collected fish species. Diphenhydramine and diltiazem were observed in plasma of multiple species, and diltiazem exceeded human therapeutic doses in largemouth bass, catfish, and mullet inhabiting these urban estuaries. Though the present study only examined a small number of target analytes, which represent a microcosm of the exposome of these fish, coastal systems are anticipated to be more strongly influenced by continued urbanization, altered instream flows, and population growth in the future. Unfortunately, aquatic toxicology information for diltiazem and many other pharmaceuticals is not available for marine and estuarine organisms, but such field observations suggest that potential adverse outcomes should be examined.

Effects of pulsed atrazine exposures on autotrophic community structure, biomass, and production in field-based stream mesocosms

The authors performed a multiple-pulsed atrazine experiment to measure responses of autotrophic endpoints in outdoor stream mesocosms. The experiment was designed to synthetically simulate worst-case atrazine chemographs from streams in agricultural catchments to achieve 60-d mean concentrations of 0 μg/L (control), 10 μg/L, 20 μg/L, and 30 μg/L. The authors dosed triplicate streams with pulses of 0 μg/L, 50 μg/L, 100 μg/L, and 150 μg/L atrazine for 4 d, followed by 7 d without dosing. This 11-d cycle occurred 3 times, followed by a recovery (untreated) period from day 34 to day 60. Mean ± standard error 60-d atrazine concentrations were 0.07 ± 0.03 μg/L, 10.7 ± 0.05 μg/L, 20.9 ± 0.24 μg/L, and 31.0 ± 0.17 μg/L for the control, 10-μg/L, 20-μg/L, and 30-μg/L treatments, respectively. Multivariate analyses revealed that periphyton and phytoplankton community structure did not differ among treatments on any day of the experiment, including during the atrazine pulses. Control periphyton biomass in riffles was higher immediately following the peak of the first atrazine pulse and remained slightly higher than some of the atrazine treatments on most days through the peak of the last pulse. However, periphyton biomass was not different among treatments at the end of the present study. Phytoplankton biomass was not affected by atrazine. Metaphyton biomass in pools was higher in the controls near the midpoint of the present study and remained higher on most days for the remainder of the study. Ceratophyllum demersum, a submersed macrophyte, biomass was higher in controls than in 20-μg/L and 30-μg/L treatments before pulse 3 but was not different subsequent to pulse 3 through the end of the present study. Maximum daily dissolved oxygen (DO, percentage of saturation) declined during each pulse in approximate proportion to magnitude of dose but rapidly converged among treatments after the third pulse. However, DO increased in controls relative to all atrazine treatments during the last 17 d of the experiment, likely a result of metaphyton cover in the pools. Finally, atrazine significantly limited uptake of PO4(3-) and uptake and/or denitrification of NO3(-) but only during pulses; percentage of dose removed from the water column was >85% for P and >95% for N after pulse 3 through the end of the present study. Collectively, only DO and metaphyton biomass differed at the end of the present study and only slightly. Some other endpoints were affected but only during pulses, if at all. The high levels of primary production and accumulation of algal biomass in all streams suggest that effects of pulses of atrazine at the concentrations used in the present study appear transient and likely do not represent ecologically significant adverse outcomes to periphyton, phytoplankton, and aquatic macrophytes, particularly in agricultural streams subjected to high nutrient loads.

Spatio-temporal bioaccumulation and trophic transfer of ionizable pharmaceuticals in a semi-arid urban river influenced by snowmelt

Bioaccumulation of pharmaceuticals in aquatic organisms is increasingly reported in the peer-reviewed literature. However, seasonal instream dynamics including occurrence and bioaccumulation across trophic positions are rarely studied, particularly in semiarid streams with flows influenced by seasonal snowmelt and municipal effluent discharges. Thus, we selected East Canyon Creek in Park City, Utah, USA to examine spatio-temporal bioaccumulation of select ionizable pharmaceuticals across trophic positions using trophic magnification factors calculated at incremental distances (0.15, 1.4, 13 miles) downstream from a municipal effluent discharge during spring (May), Summer (August), and fall (October). Nine target analytes were detected in all species during all sampling events. Trophic dilution was consistently observed for amitriptyline, caffeine, diphenhydramine, diltiazem, fluoxetine, and sertraline, regardless of seasonal instream flows or distance from effluent discharge. Calculated TMFs ranged from 0.01-0.71 with negative slopes observed for all regressions of chemical residue in tissue and trophic position. We further presents the first empirical investigation of normalizing pharmaceutical concentrations to lipid, phospholipid or protein fractions using pair matched fish samples. Empirical results identify that normalization of ionizable pharmaceutical residues in aquatic tissues to neutral lipids, polar lipids, or the total protein fraction is inappropriate, though bioaccumulation studies examining influences of internal partitioning (e.g., plasma proteins) are needed.

Spatial and temporal influence of onsite wastewater treatment systems, centralized effluent discharge, and tides on aquatic hazards of nutrients, indicator bacteria, and pharmaceuticals in a coastal bayou

In the rapidly urbanizing watersheds and estuaries flowing to the Gulf of Mexico in Texas, USA, instream flows are increasingly influenced by point source and nonpoint source discharges. Spatial and temporal tidal influences on water quality, especially for contaminants of emerging concern (CECs), is poorly understood in estuaries and coastal systems. We selected Dickinson Bayou, an urban estuary in Galveston County, Texas, for study because it has historically impaired water quality, receives point source discharge from one major wastewater treatment plant (WWTP), while also being influenced by high densities of onsite sewage facilities upstream in the watershed. We explored the occurrence and potential hazards of aquatic contaminants, including nutrients, indicator bacteria for pathogens, and CECs, in relation to this point source discharge, across seasons and at high and low tides. Aquatic contaminants and associated hazards varied significantly in relation to the WWTP discharge, and were influenced by onsite systems. In fact, spatiotemporal water quality varied by class of contaminants (e.g., nutrients, indicator bacteria, CECs), which indicates that traditional surface water monitoring activities should account for such environmental complexity. This study provides a diagnostic approach for future studies of emerging water quality challenges across gradients of rapidly urbanizing coastal bays and estuaries.

Identification of novel uncertainty factors and thresholds of toxicological concern for health hazard and risk assessment: Application to cleaning product ingredients

Uncertainty factors (UFs) are commonly used during hazard and risk assessments to address uncertainties, including extrapolations among mammals and experimental durations. In risk assessment, default values are routinely used for interspecies extrapolation and interindividual variability. Whether default UFs are sufficient for various chemical uses or specific chemical classes remains understudied, particularly for ingredients in cleaning products. Therefore, we examined publicly available acute median lethal dose (LD50), and reproductive and developmental no-observed-adverse-effect level (NOAEL) and lowest-observed-adverse-effect level (LOAEL) values for the rat model (oral). We employed probabilistic chemical toxicity distributions to identify likelihoods of encountering acute, subacute, subchronic and chronic toxicity thresholds for specific chemical categories and ingredients in cleaning products. We subsequently identified thresholds of toxicological concern (TTC) and then various UFs for: 1) acute (LD50s)-to-chronic (reproductive/developmental NOAELs) ratios (ACRs), 2) exposure duration extrapolations (e.g., subchronic-to-chronic; reproductive/developmental), and 3) LOAEL-to-NOAEL ratios considering subacute/acute developmental responses. These ratios (95% CIs) were calculated from pairwise threshold levels using Monte Carlo simulations to identify UFs for all ingredients in cleaning products. Based on data availability, chemical category-specific UFs were also identified for aliphatic acids and salts, aliphatic alcohols, inorganic acids and salts, and alkyl sulfates. In a number of cases, derived UFs were smaller than default values (e.g., 10) employed by regulatory agencies; however, larger UFs were occasionally identified. Such UFs could be used by assessors instead of relying on default values. These approaches for identifying mammalian TTCs and diverse UFs represent robust alternatives to application of default values for ingredients in cleaning products and other chemical classes. Findings can also support chemical substitutions during alternatives assessment, and data dossier development (e.g., read across), identification of TTCs, and screening-level hazard and risk assessment when toxicity data is unavailable for specific chemicals.